C-013-404, NCT02420444: A Study for Safety and Immunogenicity of BCG and AERAS-404 in HIV-Negative, TB-Negative, BCG-Naive Adults |
|
|
| Completed | 1 | 70 | Europe | BCG SSI, BCG Vaccine SSI Danish, bacillus Calmette-Guérin, Placebo, Sterile buffered saline, AERAS-404, H4:IC31 | Aeras, Sanofi Pasteur, a Sanofi Company | Tuberculosis | 05/12 | 11/13 | | |
